4 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... thrombosis; PE = pulmonary ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Spontaneous • Calf ... post-thrombotic syndrome ... #anticoagulation ... #duration #management ... #length #treatment
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #hematology #diagnosis ... #management #hematology